# EDGAR Filing Document

**Accession Number:** 0001871700
**File Stem:** 0001437749-25-019171
**Filing Date:** 2025-6
**Character Count:** 7426
**Document Hash:** 52bca40ef79cb9e1c36e29b61905b1c8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-25-019171.hdr.sgml**: 20250602

**ACCESSION NUMBER**: 0001437749-25-019171

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250529

**FILED AS OF DATE**: 20250602

**DATE AS OF CHANGE**: 20250602

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** SHADAN MARTHA
- **CENTRAL INDEX KEY:** 0001871700

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-33092
- **FILM NUMBER:** 251015367

**MAIL ADDRESS:**
- **STREET 1:** 9201 W BROADWAY AVE
- **STREET 2:** #650
- **CITY:** MINNEAPOLIS
- **STATE:** MN
- **ZIP:** 55445
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** LEMAITRE VASCULAR INC
- **CENTRAL INDEX KEY:** 0001158895
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 63 SECOND AVENUE
- **CITY:** BURLINGTON
- **STATE:** MA
- **ZIP:** 01803
- **BUSINESS PHONE:** 781-221-2266

**MAIL ADDRESS:**
- **STREET 1:** 63 SECOND AVENUE
- **CITY:** BURLINGTON
- **STATE:** MA
- **ZIP:** 01803

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>SHADAN MARTHA<br><sub>(Last) (First) (Middle)</sub><br>C/O LEMAITRE VASCULAR, INC.<br>63 SECOND AVENUE<br><sub>(Street)</sub><br>BURLINGTON, MA 01803<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-05-29 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>LEMAITRE VASCULAR INC [ LMAT ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Dividend Equivalent Rights | <sup>(1)</sup> | 2025-05-29 |  | A |  | 0.49850 |  | <sup>(1)</sup> | <sup>(1)</sup> | Common Stock | 0.49850 | $0 | 6.09830 | D |  |
| Dividend Equivalent Rights | <sup>(2)</sup> | 2025-05-29 |  | A |  | 0.49850 |  | <sup>(2)</sup> | <sup>(2)</sup> | Common Stock | 0.49850 | $0 | 5.1096 | D |  |
| Dividend Equivalent Rights | <sup>(3)</sup> | 2025-05-29 |  | A |  | 0.8524 |  | <sup>(3)</sup> | <sup>(3)</sup> | Common Stock | 0.8524 | $0 | 4.6837 | D |  |
| Dividend Equivalent Rights | <sup>(4)</sup> | 2025-05-29 |  | A |  | 1.0208 |  | <sup>(4)</sup> | <sup>(4)</sup> | Common Stock | 1.0208 | $0 | 5.0145 | D |  |
| Dividend Equivalent Rights | <sup>(5)</sup> | 2025-05-29 |  | A |  | 1.0387 |  | <sup>(5)</sup> | <sup>(5)</sup> | Common Stock | 1.0387 | $0 | 2.0397 | D |  |

---

### Footnotes:

(1) These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

(2) These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

(3) These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/23 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

(4) These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/23 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

(5) These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/24 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

**Signature:** /s/ Nathan Ulrich  
**Date:** 2025-06-02

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**